|
| 1 | TABLET,CLOBAZAM BP 5mg |
| 2 | TABLET,DEFERASIROX 400mg DISPERSABLE |
| 3 | TABLET,DEFLAZACORT 6mg |
| 4 | TABLET,ISONIAZID 300mg |
| 5 | TABLET,PREDNISOLONE,20 mg |
| 6 | TABLET,RIFAMPICIN 100mg + ISONIAZID 50mg |
| 7 | TABLET,ISONIAZID,100 mg + RIFAMPICIN 100 mg |
| 8 | VITAMIN D3,1000 IU |
| 9 | TABLET,ZINC SULPHATE,20 mg |
| 10 | TABLET, MONTELUKAST SODIUM 5MG |
| 11 | TAB. OXCARBAZEPINE 150MG |
| 12 | TAB. METHOTREXATE 7.5MG |
| 13 | TABLET, LANSOPRAZOLE ORALLY DISINTEGRATING 15 MG |
| 14 | CAPSULE,OSELTAMIVIR PHOSPHATE,75 mg |
| 15 | DROP,FUNGAL DIASTASE IP(1:2000) 20mg (DERIVED FROM ASPERGILLUS ORYZAE) + CINNAMON OIL BP 200UG + CARAWAY OIL BP 400UG + CARDAMOM OIL BP 400UG IN EACH ML (BOTTLE OF MINIMUM 15 ML) |
| 16 | DROP,IRON EACH 1ml SHOULD CONTAIN MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING: ELEMENTAL IRON 25mg, FOLIC ACID 200mcg & VIT B12 5mcg |
| 17 | DROP,VITAMIN D3(400IU/ml) MINIMUM 30 ML BOTTLE |
| 18 | MULTIVITAMIN DROPS 15 ML, EACH ML SHOULD CONTAIN VIT D 200 IU, BETA CAROTENE 18 MG + VIT.B6 0.5 MG + NIACIN 5 MG + B12 1 MCG + BIOTIN 5 MCG + LYSINE 30 MG + ZING 2 MG + MN 3 MCG + IODINE 20 MCG + CR 1 MG |
| 19 | SOLUTION,INTRAVENOUS AMINOACID 10%,100ml/BOTTLE21 TYPE OF AMINO ACID,COMPOSITION 1l CONTAIN ACTIVE CONSTITUENTS-L-ISOLEUCINE 6.400g,L-LEUCINE 10.750g,L-LYSINE MONOACETATE 10.000g,L-LYSINE 7.09g,L-METHIONINE 4.620g,ACE |
| 20 | INJECTION,DIPHTHERIA,PERTUSSIS&TETANUS VACCINE 0.5ml |
| 21 | INJECTION,DIPHTHERIA AND TETANUS TOXOID VACCINE FOR ADULTS AND ADOLESCENTS CONTAINING DIPTHERIA TOXOID-2 LF TETANUS TOXOID-5 LF PER 0.5ml AMPOULE |
| 22 | INJECTION,DIPTHERIA,TETANUS,PERTISSIS(WHOLE CELL) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORDEB) IP.0.5ml |
| 23 | INJECTION,HEPATITIS B VACCINE 10ml/VIAL |
| 24 | INJECTION,HEPATITIS B VACCINE,SINGLE DOSE,0.5ml |
| 25 | INJECTION, RECOMBINANT LIQUID GROWTH HORMONE, 30IU / CARTRIDGE |
| 26 | INJECTION,INTRAVENOUS FAT EMULSION 20% (FOUR TYPES OF LIPID) 20% INTRALIPID 1000ml OF EMULSION CONTAINS-PURIFIED SOYABEAN OIL 200mg, PURIFIED EGG PHOSPHOLIPID, GLYCEROL ANHYDROUS SODIUM HYDROXIDE & WATER FOR INJECTIONS,100ml/BOTTLE |
| 27 | MEASLES,MUMPS AND RUBELLA VACCINEVIAL OF 0.5 ML |
| 28 | INJECTION,RABIES VACCINE,1DOSE/PACK |
| 29 | INJECTION,SODIUM VALPROATE 100 mg/5 ml |
| 30 | INJECTION,TETANUS TOXIDE 0.5ml |
| 31 | INJECTION,VANCOMYCIN HYDROCHLORIDE,500 mg VIAL OF 10 ml |
| 32 | INJECTION, RECOMBINANT RABIES HUMAN MONOCLONAL ANTIBODY 100 IU/2.5ML |
| 33 | INJECTION, CAFFEINE CITRATE 20MG/ML VIAL OF 1ml |
| 34 | INJ. PHYTOMENADIONE - 1MG, 0.5ML AMP |
| 35 | INJECTION, DIPTHERIA TOXOID NOT LESS THAN 30 IU, TETENUS TOXOIDNOT LESS THAN 40IU,BORDETELLA PERTUSSIS ANTIGEN NOT LESS THAN4IU,RECOMBINANT HEPATITIS B SURFACE ANTIGEN 10 MG,HEMOPHILOUSINFLUENZA TYPE B POLYSACCHARIDE CONJUGATED TO TT 20-40 MCG,INACTIVATED POLIO VIRUS VACCINE(TYPE1-40D,TYPE-2 8D,TYPE-3 32DANTIGEN UNIT) , 0.5ML |
| 36 | INJECTION, TUROCTOCOG ALFA PEGOL-1000 IU |
| 37 | BUDESONIDE 100 MCG INHALER 200 METERED DOSE |
| 38 | RESPULE,LEVOSALBUTAMOL 0.31mg |
| 39 | SOLUTION,LEVOSALBUTAMOL INHALATION,LEVOSALBUTAMOL SULPHATE IP 0.63 mg |
| 40 | SALMETROL 25 MCG + FLUTICASONE PROPIONATE IP 50 MC BOTT OF 120 METERED DOSE |
| 41 | FORMOTEROL 6 MCG + BUDESONIDE 200 MCG, BOTTLE OF 120 METERED DOSE |
| 42 | FORMOTEROL 6 MCG + BUDESONIDE 100 MCG, BOTTLE OF 120 METERED DOSE |
| 43 | CREAM,PERMRTHRIN 5%,30g/TUBE |
| 44 | SYRUP,AMOXYCILLINE 200mg/5ml + CLAVULANIC ACID 28.5mg/5ml,30ml/BOTTLE |
| 45 | SYRUP,AZITHROMYCIN,200mg/5ml,15ml/BOTTLE |
| 46 | SYRUP,CALCIUM SUSPENSION,EACH 5ml OF SUSPENSION SHOULD CONTAIN (CALCIUM PHOSPHATE ATLEAST 200mg (ELEMENTAL CALCIUM 82mg) + VITAMIN D3 ATLEAST 200 IU),200ml/BOTTLE |
| 47 | SYRUP,IBUPROFEN 100mg/5ml,60ml/BOTTLE |
| 48 | SYRUP,IRON SUSPENSION EACH 5ml SHOULD CONTAIN MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING ELEMENTAL IRON 80mg FOLIC ACID 500mcg:VITAMIN B12 5mcg |
| 49 | LACTOBACILLIUS CELLS,40 MILLION/5ml,60ml/BOTTLE |
| 50 | SYRUP LEVOCETRIZINE HYDROCHLORIDE 2.5MG/5ML. BOTT. OF 30 ML. |
| 51 | SYRUP,METRONIDAZOLE 100mg/5ml SUSPENSION,60ml/BOTTLE |
| 52 | SYRUP,ONDANSETRON,2mg/5ml,30ml/BOTTLE |
| 53 | SYRUP,PHENYLEPHRINE HYDROCHLORIDE IP 5mg,CHLORPHENIRAMINE MALEATE IP 1mg SODIUM CITRATE IP 60mg MENTHOL IP 1mg |
| 54 | SYRUP, ELEMENTAL ZINC, 20 MG / 5 ML BOTTLE OF MINIMUM 60 ML |
| 55 | SOLUTION, VITAMIN D3 60000 IU ORAL SOLUTION IN 5ML BOTTLE |
| 56 | SUSPENSION, VIT D 200IU, BETA CAROTENE - 38 MG, VIT B6 - 1 MG, NIACIN - 15 MG, B12 - 1 MCG, BIOTIN - 10 MCG, LYSINE - 30 MG, ZINC - 3 MG, Mn - 0.8 MG, Mo - 8 MCG, IODINE - 50 MCG, Cr - 10 MCG, Se - 10 MCG, BOTTLE OF 200 ML |
| 57 | TABLET,BETAHISTINE 8mg |
| 58 | TABLET,CINNARIZINE 25mg |
| 59 | TABLET,DESLORATADINE 5mg |
| 60 | TABLET,FEXOFENADINE 180mg |
| 61 | TABLET,METHYLPREDNISOLONE 4mg |
| 62 | DROP,CHLORAMPHENICOL I.P 5% W/V + BECLOMETHASONE DIPROPIONATE I.P 0.025% W/V +CLOTROMAZOLE I.P 1% W/V + LIGNOCAINE HCL I.P 25W/V |
| 63 | CLOTRIMAZOLE 1% W/V+LIGNOCAINECL 2% W/V EAR DROPS BOTT.OF 10 ML |
| 64 | FLUTICASONE PROPIONATE 0.5% + BENZALKONIUM HCL NF 0.01%+ PHENYLETHYLCORD 0.25% 100/150 METERED DOSE NASAL SPRAY |
| 65 | ISOTONIC NASAL SPRAY (SODIUM CHLORIDE IP 0.9% W/V IN PURIFIED WATER IP) |
| 66 | NASAL SPRAY,MOMETASONE AQEOUS 100/150,METERED DOSE |
| 67 | DROP,NASAL,OXYMETAZOLINE HCL 0.05%,10ml/BOTTLE |
| 68 | DROP,NASAL,OXYMETAZOLINE HCL USP 0.025%(P),10ml/BOTTLE |
| 69 | DROP,EAR,PARACHLOROBENZONE 2% + BENZOCAINE 2.7% W/V + CHLOROBUTANOL 5% + TURPENTINE OIL 15%, MINIMUM 10ml/BOTTLE |
| 70 | DROP,SODIUM CHLORIDE NASAL 0.65%, MINIMUM 15ml BOTTLE |
| 71 | DROP, CIPROFLOXACIN 0.3%W/V, DEXAMETHASONE 0.1% W/V, BENZALKONIUM CHLORIDE NF 0.015W/W |
| 72 | OINTMENT,CHOLINE SALICYLATE (ATLEAST 8%) WITH LIGNOCAINE HYDROCHLORIDE 2% W/W WITH OR WITHOUT BENZALKONIUM CHLORIDE (ATLEAST 0.01%W/V),MINIMUM 10gm/TUBE |
| 73 | METRONIDAZOLE GEL 1.5% W/W, METRONIDAZOLE BENZOATE IP EQUIVALENT TO METRONIDAZOLE 1.5% W/W, CHLORHEXIDINE GLUCONATE SOLUTION IP 0.5% W/W (AS PRESERVATIVE) WATER SOLUBLE GEL BASE Q.S., TUBE MINIMUM 20 GM |
| 74 | TUBE,TRIAMCENALONE ACETATE 0.1% FOR INTRAORAL APPLICATION OF MINIMUM 5 g |
| 75 | GARGLE,SOLUTION CHLORHEXIDINE GLUCONATE 0.2% W/V MINIMUM 100 ML BOTTLE |
| 76 | SOLUTION,POVIDONE IODINE 2% GARGLES, MINIMUM 50ml/BOTTLE |
| 77 | TABLET,ACETAZOLAMIDE 250mg |
| 78 | DROP,EYE,BIMATOPROST 0.03% |
| 79 | DROP,EYE,BRIMONIDINE TARTRATE 0.1%, MINIMUM 5ml BOTTLE |
| 80 | DROP,EYE,BRIMONIDINE TARTRATE 0.15% + TIMOLOL MALEATE 0.5%, MINIMUM 5ml BOTTLE |
| 81 | DROP,EYE,BRINZOLAMIDE 1% W/V |
| 82 | DROP,EYE,CARBOXY METHYLCELLULOSE SODIUM 1% IN TEAL, GREEN BOTTLE |
| 83 | DROP,CARBOXYMETHYL CELLULOSE 0.5% IN TEAL GREEN BOTTLE |
| 84 | DROP,EYE,DORZOLAMIDE HYDROCHLORIDE OPTHALMIC SOLUTION 2% W/V, MINIMUM 5ml BOTTLE |
| 85 | DROP,EYE,HOMATROPINE, MINIMUM 5ml BOTTLE |
| 86 | DROP,EYE,HYDROXYPROPYL METHYL CELLULOSE 0.3% INACTIVE SODIUM PERBORATE, BORIC ACID, PHOSPHONIC ACID, POTASSIUM CHLORIDE, PURIFIED WATER & SODIUM CHLORIDE, MINIMUM 10ml BOTTLE |
| 87 | Drop LATANOPROST 0.005% WITH BKC FREE) |
| 88 | LOTEPREDNOL ETABONATE 0.5% |
| 89 | DROP,LATANOPROST 0.005% W/V + TIMOLOL MALEATE 0.5%, MINIMUM 2.5ml BOTTLE |
| 90 | MOXIFLOXACIN 0.5% WITH DROP TAINER SYSTEM, NEUTRAL PH 6.8, OSMOLARITY 290 mosm/Kg, MINIMUM 5 ML (WITH LPD BOTTLE) |
| 91 | NORFLOXACIN0.3 %W/V + BENZALKONIUMCHLORIDE 0.01 %W/V EYE DROP, MINIMUM 5 ML BOTTLE |
| 92 | OLOPATADINE HYDROCHLORIDE USP EQUIVALENT TO OLOPATADINE 2 mg,BENZALKONIUM CHLORIDE SOLUTION IP 0.02% W/V |
| 93 | DROP,PHENYLPHRINE HCL 0.12% + NAPHAZOLINE HCL 0.05% + MENTHOL 0.005% + CAMPHOR 66 0.01% + BENZALCONIUM CHLORIDE 0.01%, MINIMUM 05ml BOTTLE |
| 94 | DROP,PILOCARPINE NITRATE 2%, MINIMUM 5ml BOTTLE |
| 95 | DROP,EYE,PROPARACAINE HCL 0.5%, MINIMUM 5ml BOTTLE |
| 96 | POVIDONE IODINE 5% BOTT/5 ML |
| 97 | POLYETHYLENE GLYCOL 400,0.4% W/V AND PROPYLENE GLYCOL 0.3%, POLYQUAD 0.001%W/V AS PRESERVATIVE MINIMUM 3 ML BOTTLE |
| 98 | DROP,EYE,SODIUM CHLORIDE 5% |
| 99 | TIMOLOL MALEATE 0.5% EYE DROPSBOTTLE OF MINIMUM 5 ML |
| 100 | DROP,TROPICAMIDE I.P 0.8% W/V, PHENYLEPHRINE HYDROCHLORIDE I.P 5.0% W/V, MINIMUM 3ml BOTTLE |
| 101 | DROP,EYE,TRAVOPROST 0.004% W/V,BKC FREE, MINIMUM 2.5ml BOTTLE |
| 102 | DROP,TRAVOPROST 0.04% W/V + TIMOLOL MALEATE 0.5%,BKC FREE, MINIMUM 2.5ml BOTTLE |
| 103 | DROP,TOBRAMYCIN 0.3% + FLUORMETHOLONE ACETATE 0.1%, MINIMUM 5ml BOTTLE |
| 104 | EYE DROP, MOXIFLOXACIN HYDROCHLORIDE EQUIVALENT TO MOXIFLOXACIN 5 MG, DEXAMETHASONE SODIUM PHOSPHATE EQUIVALENT TO DEXAMETHASONE PHOSPHATE USP 1 MG |
| 105 | DROP, NEPAFENAC 3MG WITH 1ML OF SOLUTION |
| 106 | TRAVOPROST 0.004% + TIMOLOL MALEATE 0.5% EYE DROPS PRESERVATIVE FREE, BOTTLE OF MINIMUM 5 ML METERED DOSE PACK |
| 107 | DORZOLAMIDE 2% + TIMOLOL MALEATE 0.5% EYE DROPS PRESERVATIVE FREE, BOTTLE OF MINIMUM 10 ML METERED DOSE PACK |
| 108 | CYCLOSPORINE MNP 0.05% EYE DROPS PRESERVATIVE FREE, BOTTLE OF MINIMUM 5 ML METERED DOSE PACK |
| 109 | DROP,EYE,TRAVOPROST 0.004% PRESERVATIVE FREE, MINIMUM 5ml BOTTLE |
| 110 | SODIUM HYALURONATE 0.18% EYE DROPS, PRESERVATIVE FREE BOTTLE OF MINIMUM 10 ML METERED DOSE PACK |
| 111 | INJECTION,BEVACIZUMAB 100mg / 4ml, PRESERVATIVE FREE, STERILE SOLUTION |
| 112 | HYALURONIDASE (1500 IU)INJ AMP OF 1ML |
| 113 | HYDROXYPROPYLMETHYL CELLULOSE2% IN PREFILLED SYRINGE |
| 114 | CAPSULE,CHLOROMYCETIN APPLICAP,MINIMUM 50/BOTTLE |
| 115 | OINTMENT,GATIFLOXACIN + WHITE SOFT PARAFFIN,5mg/TUBE |
| 116 | OINTMENT,NEOMYCIN AND POLYMYCIN B SULPHATE AND BACITRACIN ZINC OPTHALMIC OINTMENT EACH GRAM CONTAINS NEOMYCIN SULPHATE IP 3400 UNITS, POLYMYXIN B SULPHATE USP 5000 UNITS AND BACITRACIN ZINC IP 400 UNITS, OPTHALMIC OINTMENT USP,5g/TUBE |
| 117 | INJECTION RANIBIZUMAB 10 MG/ML, IN PRE FILLED SYRINGE, CONTAINING 0.16 ML SOLUTION FOR OPTHALMIC USE WITH STERILE 30G NEEDLE |
